235 related articles for article (PubMed ID: 25639184)
1. Initial gene vector dosing for studying symptomatology of amyotrophic lateral sclerosis in non-human primates.
Jackson KL; Dayton RD; Fisher-Perkins JM; Didier PJ; Baker KC; Weimer M; Gutierrez A; Cain CD; Mathis JM; Gitcho MA; Bunnell BA; Klein RL
J Med Primatol; 2015 Apr; 44(2):66-75. PubMed ID: 25639184
[TBL] [Abstract][Full Text] [Related]
2. Genetic strategies to study TDP-43 in rodents and to develop preclinical therapeutics for amyotrophic lateral sclerosis.
Wang DB; Gitcho MA; Kraemer BC; Klein RL
Eur J Neurosci; 2011 Oct; 34(8):1179-88. PubMed ID: 21777407
[TBL] [Abstract][Full Text] [Related]
3. Non-human primate model of amyotrophic lateral sclerosis with cytoplasmic mislocalization of TDP-43.
Uchida A; Sasaguri H; Kimura N; Tajiri M; Ohkubo T; Ono F; Sakaue F; Kanai K; Hirai T; Sano T; Shibuya K; Kobayashi M; Yamamoto M; Yokota S; Kubodera T; Tomori M; Sakaki K; Enomoto M; Hirai Y; Kumagai J; Yasutomi Y; Mochizuki H; Kuwabara S; Uchihara T; Mizusawa H; Yokota T
Brain; 2012 Mar; 135(Pt 3):833-46. PubMed ID: 22252998
[TBL] [Abstract][Full Text] [Related]
4. Severe respiratory changes at end stage in a FUS-induced disease state in adult rats.
Jackson KL; Dhaibar HA; Dayton RD; Cananzi SG; Mayhan WG; Glasscock E; Klein RL
BMC Neurosci; 2016 Oct; 17(1):69. PubMed ID: 27793099
[TBL] [Abstract][Full Text] [Related]
5. Rescue of amyotrophic lateral sclerosis phenotype in a mouse model by intravenous AAV9-ADAR2 delivery to motor neurons.
Yamashita T; Chai HL; Teramoto S; Tsuji S; Shimazaki K; Muramatsu S; Kwak S
EMBO Mol Med; 2013 Nov; 5(11):1710-9. PubMed ID: 24115583
[TBL] [Abstract][Full Text] [Related]
6. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments.
Swarup V; Phaneuf D; Bareil C; Robertson J; Rouleau GA; Kriz J; Julien JP
Brain; 2011 Sep; 134(Pt 9):2610-26. PubMed ID: 21752789
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis.
Wang LJ; Lu YY; Muramatsu S; Ikeguchi K; Fujimoto K; Okada T; Mizukami H; Matsushita T; Hanazono Y; Kume A; Nagatsu T; Ozawa K; Nakano I
J Neurosci; 2002 Aug; 22(16):6920-8. PubMed ID: 12177190
[TBL] [Abstract][Full Text] [Related]
8. Mimicking aspects of frontotemporal lobar degeneration and Lou Gehrig's disease in rats via TDP-43 overexpression.
Tatom JB; Wang DB; Dayton RD; Skalli O; Hutton ML; Dickson DW; Klein RL
Mol Ther; 2009 Apr; 17(4):607-13. PubMed ID: 19223871
[TBL] [Abstract][Full Text] [Related]
9. [Creation of an animal model of ALS by overexpression of TDP-43].
Yokota T
Rinsho Shinkeigaku; 2010 Nov; 50(11):943-4. PubMed ID: 21921520
[No Abstract] [Full Text] [Related]
10. Preservation of forelimb function by UPF1 gene therapy in a rat model of TDP-43-induced motor paralysis.
Jackson KL; Dayton RD; Orchard EA; Ju S; Ringe D; Petsko GA; Maquat LE; Klein RL
Gene Ther; 2015 Jan; 22(1):20-8. PubMed ID: 25354681
[TBL] [Abstract][Full Text] [Related]
11. Short-term suppression of A315T mutant human TDP-43 expression improves functional deficits in a novel inducible transgenic mouse model of FTLD-TDP and ALS.
Ke YD; van Hummel A; Stevens CH; Gladbach A; Ippati S; Bi M; Lee WS; Krüger S; van der Hoven J; Volkerling A; Bongers A; Halliday G; Haass NK; Kiernan M; Delerue F; Ittner LM
Acta Neuropathol; 2015 Nov; 130(5):661-78. PubMed ID: 26437864
[TBL] [Abstract][Full Text] [Related]
12. Expansive gene transfer in the rat CNS rapidly produces amyotrophic lateral sclerosis relevant sequelae when TDP-43 is overexpressed.
Wang DB; Dayton RD; Henning PP; Cain CD; Zhao LR; Schrott LM; Orchard EA; Knight DS; Klein RL
Mol Ther; 2010 Dec; 18(12):2064-74. PubMed ID: 20877346
[TBL] [Abstract][Full Text] [Related]
13. Adeno-associated virus-delivered artificial microRNA extends survival and delays paralysis in an amyotrophic lateral sclerosis mouse model.
Stoica L; Todeasa SH; Cabrera GT; Salameh JS; ElMallah MK; Mueller C; Brown RH; Sena-Esteves M
Ann Neurol; 2016 Apr; 79(4):687-700. PubMed ID: 26891182
[TBL] [Abstract][Full Text] [Related]
14. Widespread spinal cord transduction by intrathecal injection of rAAV delivers efficacious RNAi therapy for amyotrophic lateral sclerosis.
Wang H; Yang B; Qiu L; Yang C; Kramer J; Su Q; Guo Y; Brown RH; Gao G; Xu Z
Hum Mol Genet; 2014 Feb; 23(3):668-81. PubMed ID: 24108104
[TBL] [Abstract][Full Text] [Related]
15. Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Riku Y; Watanabe H; Yoshida M; Tatsumi S; Mimuro M; Iwasaki Y; Katsuno M; Iguchi Y; Masuda M; Senda J; Ishigaki S; Udagawa T; Sobue G
JAMA Neurol; 2014 Feb; 71(2):172-9. PubMed ID: 24378564
[TBL] [Abstract][Full Text] [Related]
16. The role of mutant TAR DNA-binding protein 43 in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
Janssens J; Kleinberger G; Wils H; Van Broeckhoven C
Biochem Soc Trans; 2011 Aug; 39(4):954-9. PubMed ID: 21787329
[TBL] [Abstract][Full Text] [Related]
17. Mutant TDP-43 in motor neurons promotes the onset and progression of ALS in rats.
Huang C; Tong J; Bi F; Zhou H; Xia XG
J Clin Invest; 2012 Jan; 122(1):107-18. PubMed ID: 22156203
[TBL] [Abstract][Full Text] [Related]
18. Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43.
Walker AK; Spiller KJ; Ge G; Zheng A; Xu Y; Zhou M; Tripathy K; Kwong LK; Trojanowski JQ; Lee VM
Acta Neuropathol; 2015 Nov; 130(5):643-60. PubMed ID: 26197969
[TBL] [Abstract][Full Text] [Related]
19. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.
Mackenzie IR; Rademakers R
Curr Opin Neurol; 2008 Dec; 21(6):693-700. PubMed ID: 18989115
[TBL] [Abstract][Full Text] [Related]
20. A New AAV10-U7-Mediated Gene Therapy Prolongs Survival and Restores Function in an ALS Mouse Model.
Biferi MG; Cohen-Tannoudji M; Cappelletto A; Giroux B; Roda M; Astord S; Marais T; Bos C; Voit T; Ferry A; Barkats M
Mol Ther; 2017 Sep; 25(9):2038-2052. PubMed ID: 28663100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
